In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Koninklijke DSM N.V.

http://www.dsm.com/

Latest From Koninklijke DSM N.V.

FDA’s Disparate Treatment Of Fibrinogen Products ‘Defies Logic,’ Octapharma Contends

Suit says FDA wrongly classified the fibrinogen products of three blood centers as ‘blood components’ exempt from clinical trials while classifying Octapharma’s Fibryga as a ‘blood derivative’ subject to clinical studies.

Legal Issues Drug Approval Standards

P&G Ventures Startup Incubator Yields Supplements For Menopause Symptoms

P&G Ventures startup's partnership with venture capital group M13 delivered its first brand, the Kindra four-product, hormone-free menopausal line. Kindra says its products provide relief from the seven symptoms of menopause in a market largely neglected.

Dietary Supplements Commercial

Omega-3 Firms Parse Amarin's Fair Trade Complaint Into Tariff Act Questions

Attorneys for DSM, Pharmavite and Nordic Naturals pose two questions they say the Supreme Court is being asked in Amarin's request for a fair trade investigation. One is whether under Tariff Act, Federal Circuit lacks jurisdiction to review an ITC decision not to investigate? The second concerns an attempt for private enforcement of FDA regulations framed as a complaint to force an investigation under the Tariff Act.

Dietary Supplements Legal Issues

Amarin's Asking ITC To Do FDA's Job, Federal Attorneys Tell Supreme Court

In petition to Supreme Court, Amarin does not assert it makes any fair trade claim "that could be proved without establishing" an FDCA violation, nor does it dispute that its "claims are ultimately premised on allegations that the FDCA was violated," say DoJ solicitor general and ITC counsel.

Legal Issues Dietary Supplements
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Aland (HK) Holding Limited
    • Amyris Brasil Ltda
    • BioCare Copenhagen
    • DSM Biomedical
    • Fortitech, Inc.
    • Glycom A/S
    • Kensey Nash Corporation
    • Koninklijke CSK Food Enrichment C.V.
    • Royal DSM N.V.
    • Tortuga Companhia Zootecnica Agraria
    • Unitech Industries Limited
UsernamePublicRestriction

Register